The clinical benefit of acute GVHD depends on the age at transplantation in patients with adult T-cell leukemia-lymphoma on behalf of the ATL Working Group of the Japan Society for Transplantation and Cellular Therapy

Affiliations

• ¹ Department of Hematology, Osaka International Cancer Institute, Osaka, Japan. fujishige1231@gmail.com.
• ² Department of Hematology, Kumamoto University Hospital, Kumamoto, Japan.
• ³ Department of Hematology, Sasebo City General Hospital, Nagasaki, Japan.
• ⁴ Department of Hematology, Imamura General Hospital, Kagoshima, Japan.
• ⁵ Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
• ⁶ Department of Hematology, National Hospital Organization Kumamoto Medical Center, Kumamoto, Japan.
• ⁷ Department of Hematology, Hamanomachi Hospital, Fukuoka, Japan.
• ⁸ Department of Hematology and Cell Therapy, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.
• ⁹ Department of Hematology, Nagasaki University Hospital, Nagasaki, Japan.
• ¹⁰ Hematology, Oncology & Cardiovascular medicine, Kyushu University Hospital, Fukuoka, Japan.
• ¹¹ Department of Hematology, Federation of National Public Service Personnel Mutual Aid Associations Toranomon Hospital, Tokyo, Japan.
• ¹² Division of Endocrinology, Diabetes and Metabolism, Hematology, University of the Ryukyus Hospital, Okinawa, Japan.
• ¹³ Department of Hematology/Oncology, Tokai University School of Medicine, Kanagawa, Japan.
• ¹⁴ Department of Hematology and Rheumatology, Kagoshima University Hospital, Kagoshima, Japan.
• ¹⁵ Japanese Data Center for Hematopoietic Cell Transplantation, Aichi, Japan.
• ¹⁶ Department of Registry Science for Transplant and Cellular Therapy, Aichi Medical University School of Medicine, Aichi, Japan.